Publicaciones Científicas
Immunotherapy in first line treatment of adult acute lymphoblastic leukemia.
Anna Torrent; Josep-Maria Ribera
Quadruplet regimens for patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis.
Mohammad S Ebraheem; Rajshekhar Chakraborty; Bram Rochwerg; Alissa Visram; Ghulam Rehman Mohyuddin; Christopher P Venner; Irwindeep Sandhu; Arleigh McCurdy; Thierry Facon; Maria-Victoria Mateos; Hira…
Measurable residual disease by mass spectrometry and next-generation flow to assess treatment response in myeloma.
Noemí Puig; Cristina Agulló; Teresa Contreras; María-Teresa Cedena; Joaquín Martínez-López; Albert Oriol; María-Jesús Blanchard; Rafael Ríos; María-Belén Íñigo; Anna Sureda; Sunil Lakhwani; Javier de…
High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience.
Veronica González-Calle; Paula Rodriguez-Otero; Maria J Calasanz; Manuela Guijarro; Joaquin Martínez-López; Laura Rosiñol; Miguel T Hernández; Ana I Teruel; Mercedes Gironella; Albert Oriol; Javier…
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee.
Yi Lin; Lugui Qiu; Saad Usmani; Chng Wee Joo; Luciano Costa; Benjamin Derman; Juan Du; Hermann Einsele; Carlos Fernandez de Larrea; Roman Hajek; P Joy Ho; Efstathios Kastritis; Joaquin Martinez-Lopez…
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance.
María-Victoria Mateos; Joaquin Martínez-López; Paula Rodriguez Otero; Verónica González-Calle; Marta Sonia Gonzalez; Albert Oriol; Norma C Gutiérrez; Rafael Ríos-Tamayo; Laura Rosiñol; Miguel Angel…
A CD38/CD3xCD28 trispecific T-cell engager as a potentially active agent in multiple myeloma patients relapsed and/or refractory to anti-CD38 monoclonal antibodies.
Aintzane Zabaleta; Laura Blanco; Peter S Kim; Kamlesh Bisht; Hongfang Wang; Helgi Van de Velde; Marta Lasa; Luis-Esteban Tamariz-Amador; Paula Rodriguez-Otero; Jesús San-Miguel; Bruno Paiva;…
Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA
Garcia-Gisbert, N; Garcia-Avila, S; Merchan, B; Salido, M; Fernandez-Rodriguez, C; Gibert, J; Fernandez-Ibarrondo, L; Camacho, L; Lafuente, M; Longaron, R; Espinet, B; Velez, P; Pujol, RM; Andrade…
Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries
Recher, C; Rollig, C; Berard, E; Bertoli, S; Dumas, PY; Tavitian, S; Kramer, M; Serve, H; Bornhauser, M; Platzbecker, U; Muller-Tidow, C; Baldus, CD; Martinez-Cuadron, D; Serrano, J; Martinez-Sanchez…
Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromes
Saumell, S; Fernandez-Serrano, M; Mesa, A; Lopez-Cadenas, F; Arenillas, L; Alfonso, A; Montoro, MJ; Molero, A; Leoz, P; Riego, V; Gallur, L; Salamero, O; Navarrete, M; Tazon-Vega, B; Ortega, M; Reig,…